Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach

Nicotine has a broad impact on both the central and peripheral nervous systems. Over the past decades, an increasing number of genes potentially involved in nicotine addiction have been identified by different technical approaches. However, the molecular mechanisms underlying nicotine addiction remain largely unknown. Under such situation, prioritizing the candidate genes for further investigation is becoming increasingly important. In this study, we presented a multi-source-based gene prioritization approach for nicotine addiction by utilizing the vast amounts of information generated from for nicotine addiction study during the past years. In this approach, we first collected and curated genes from studies in four categories, i.e., genetic association analysis, genetic linkage analysis, high-throughput gene/protein expression analysis, and literature search of single gene/protein-based studies. Based on these resources, the genes were scored and a weight value was determined for each category. Finally, the genes were ranked by their combined scores, and 220 genes were selected as the prioritized nicotine addiction-related genes. Evaluation suggested the prioritized genes were promising targets for further analysis and replication study.

[1]  S S Smith,et al.  The epidemiology of tobacco use, dependence, and cessation in the United States. , 1999, Primary Care.

[2]  R. Peto,et al.  Global effects of smoking, of quitting, and of taxing tobacco. , 2014, The New England journal of medicine.

[3]  Phoebe M. Roberts,et al.  Mining literature for systems biology , 2006, Briefings Bioinform..

[4]  Bryan Kolb,et al.  Structural plasticity associated with exposure to drugs of abuse , 2004, Neuropharmacology.

[5]  C. Bai,et al.  Tobacco smoking in China: Prevalence, disease burden, challenges and future strategies , 2011, Respirology.

[6]  Ming D. Li,et al.  Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. , 2004, Brain research. Molecular brain research.

[7]  Sandro Ridella,et al.  Minimizing multimodal functions of continuous variables with the “simulated annealing” algorithmCorrigenda for this article is available here , 1987, TOMS.

[8]  Sally Murray.  A smouldering epidemic , 2006, Canadian Medical Association Journal.

[9]  Zhongming Zhao,et al.  Functional Features, Biological Pathways, and Protein Interaction Networks of Addiction‐Related Genes , 2010, Chemistry & biodiversity.

[10]  Liping Wei,et al.  Genes and (Common) Pathways Underlying Drug Addiction , 2007, PLoS Comput. Biol..

[11]  L. Stead,et al.  Anxiolytics and antidepressants for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[12]  Ming D. Li,et al.  Region-specific transcriptional response to chronic nicotine in rat brain , 2001, Brain Research.

[13]  G. Uhl,et al.  Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs , 2007, BMC Genetics.

[14]  M. Benwell,et al.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity , 1992, British journal of pharmacology.

[15]  D. Brunzell,et al.  In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice , 2003, Journal of neurochemistry.

[16]  M. Benwell,et al.  Regional variation in the effects of nicotine on catecholamine overflow in rat brain. , 1997, European journal of pharmacology.

[17]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[18]  Ming D. Li,et al.  Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation , 2010, Neuropsychopharmacology.

[19]  P. Madden,et al.  The genetics of tobacco use: methods, findings and policy implications , 2002, Tobacco control.

[20]  C. Husten,et al.  Cigarette Smoking Among Adults, United States , 2006 .

[21]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2014, The Cochrane database of systematic reviews.

[22]  K. Pietilä,et al.  Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water , 2001, Pharmacology Biochemistry and Behavior.

[23]  R. Gutala,et al.  Strain‐ and region‐specific gene expression profiles in mouse brain in response to chronic nicotine treatment , 2007, Genes, brain, and behavior.

[24]  M. Locatelli.  Simulated Annealing Algorithms for Continuous Global Optimization , 2002 .

[25]  Emile H. L. Aarts,et al.  Global optimization and simulated annealing , 1991, Math. Program..

[26]  S. Wonnacott,et al.  Nicotinic acetylcholine receptors and the regulation of neuronal signalling. , 2004, Trends in pharmacological sciences.

[27]  N. Martin,et al.  Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample , 2013, Molecular Psychiatry.

[28]  K. Soderstrom,et al.  Nicotine increases FosB expression within a subset of reward- and memory-related brain regions during both peri- and post-adolescence , 2007, Psychopharmacology.

[29]  A. Stromberg,et al.  Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation , 2005, Ageing Research Reviews.

[30]  Caryn Lerman,et al.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.

[31]  Prabhat Jha,et al.  Avoidable global cancer deaths and total deaths from smoking , 2009, Nature Reviews Cancer.

[32]  James W Baurley,et al.  Hierarchical Bayes prioritization of marker associations from a genome‐wide association scan for further investigation , 2007, Genetic epidemiology.

[33]  Ming D. Li,et al.  Proteins differentially expressed in response to nicotine in five rat brain regions: Identification using a 2‐DE/MS‐based proteomics approach , 2006, Proteomics.

[34]  C. Lerman,et al.  Elucidating the role of genetic factors in smoking behavior and nicotine dependence , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  Beau Dabbs,et al.  Summary and discussion of : “ Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing , 2014 .

[36]  C. Gieger,et al.  Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior , 2010, Nature Genetics.

[37]  D. Sulzer,et al.  How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.

[38]  Joel Gelernter,et al.  Meta-Analysis of 15 Genome-Wide Linkage Scans of Smoking Behavior , 2010, Biological Psychiatry.

[39]  Patrick F Sullivan,et al.  A searchable database of genetic evidence for psychiatric disorders , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  K. Pietilä,et al.  Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice. , 2006, European journal of pharmacology.

[41]  M. Reith,et al.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. , 2008, CNS & neurological disorders drug targets.

[42]  Amit P. Sheth,et al.  An ontology-driven semantic mashup of gene and biological pathway information: Application to the domain of nicotine dependence , 2008, J. Biomed. Informatics.

[43]  Gary E. Swan,et al.  Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence , 2008, Bioinform..

[44]  Ming D. Li,et al.  Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions. , 2009, Mitochondrion.

[45]  Marcus R Munafò,et al.  Genetics and smoking cessation improving outcomes in smokers at risk. , 2007, American journal of preventive medicine.

[46]  N. Millar,et al.  Changes in Conformation and Subcellular Distribution of α4β2 Nicotinic Acetylcholine Receptors Revealed by Chronic Nicotine Treatment and Expression of Subunit Chimeras , 2002, The Journal of Neuroscience.

[47]  S. Wonnacott,et al.  Indirect Modulation by α7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal , 2006, Molecular Pharmacology.

[48]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[49]  S. Chellappan,et al.  Nicotine-Mediated Cell Proliferation and Angiogenesis: New Twists to an Old Story , 2006, Cell cycle.

[50]  S. File,et al.  Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus , 2001, The European journal of neuroscience.

[51]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[52]  R. Tyndale,et al.  Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.

[53]  S. Chellappan,et al.  Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. , 2006, The Journal of clinical investigation.

[54]  C. Chiamulera,et al.  The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain , 1996, The European journal of neuroscience.

[55]  Caryn Lerman,et al.  Genetics and Drug Use as a Complex Phenotype , 2004, Substance use & misuse.

[56]  Margit Burmeister,et al.  New insights into the genetics of addiction , 2009, Nature Reviews Genetics.

[57]  M. Locatelli.  Simulated Annealing Algorithms for Continuous Global Optimization: Convergence Conditions , 2000 .

[58]  S. Wonnacott,et al.  Molecular and cellular mechanisms of action of nicotine in the CNS. , 2009, Handbook of experimental pharmacology.

[59]  R. Tyndale,et al.  Overview of the pharmacogenomics of cigarette smoking , 2007, The Pharmacogenomics Journal.

[60]  C. Husten,et al.  Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[61]  D. O'Connor,et al.  A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. , 1998, Molecular pharmacology.

[62]  Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. , 2002, MMWR. Morbidity and mortality weekly report.

[63]  Michael C Neale,et al.  Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[64]  T. Manolio,et al.  How to Interpret a Genome-wide Association Study Topic Collections , 2022 .

[65]  Ming D. Li,et al.  Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. , 2004, Brain research. Molecular brain research.

[66]  K. Chergui,et al.  Chronic Nicotine Enhances Basal and Nicotine-Induced Fos Immunoreactivity Preferentially in the Medial Prefrontal Cortex of the Rat , 1997, Neuropsychopharmacology.

[67]  T. Sørensen,et al.  Influence of genes and family environment on adult smoking behavior assessed in an adoption study , 2001, Genetic epidemiology.

[68]  Ming D. Li,et al.  Genes and Pathways Co-associated with the Exposure to Multiple Drugs of Abuse, Including Alcohol, Amphetamine/Methamphetamine, Cocaine, Marijuana, Morphine, and/or Nicotine: a Review of Proteomics Analyses , 2011, Molecular Neurobiology.

[69]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[70]  Gail P Jarvik,et al.  Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study , 2003, BMC Genetics.